TechSprouts by Ankur Capital
We are entering the third decade of synthetic biology. Many synbio products are either commercialized or on the verge of commercialization. However, scaling up the production while achieving price parities will require innovation in the processes and unit operations involved. Listen to Subramani Ramachandrappa, founder of Laurus Bio (formerly Richcore Lifesciences) and Fermbox talk about the challenges and potential solutions in the scale up of synthetic biology solutions. Bio: https://www.linkedin.com/in/subramani-ramachandrappa-7179b82/ Website: https://fermbox.bio/ TechSprouts: https://www.ankurcapital.com/techsprouts
15 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de TechSprouts by Ankur Capital!